Following this, the Editors-in-Chief concluded that the main finding of this article is not substantiated and that retraction was the appropriate editorial action to take. All authors disagreed with the retraction, the retraction notice states
Pep includes a food tracker built for GLP-1 users, with protein, fiber, calorie, and water tracking the metrics that matter most on Ozempic, Wegovy, Mounjaro, and Zepbound
however, the prevalence and natural history of diabetic gastroparesis is poorly defined A number of management strategies for patients with type 2 diabetes mellitus specifically target gastric emptying A bidirectional relationship exists between the rate of gastric emptying and glycaemia, such that the rate of gastric emptying is partially modulated by acute changes in blood glucose concentrations In patients with severe diabetic gastroparesis, histological abnormalities are heterogeneous
Evaluation of ischemia-modified albumin, oxidative stress, and antioxidant status in acute ischemic stroke patients
WT:Gnas fl/fl [saline] p = 0.0015
Compounded Drug Warning Individual Results May Vary Possible Side Effects Common side effects of GLP-1 medications may include: Nausea Vomiting Diarrhea Constipation Stomach pain or discomfort Decreased appetite Indigestion or gas Redness, itching, or soreness at the injection site Most side effects are mild to moderate and may improve as your body adjusts to treatment